Pregled bibliografske jedinice broj: 742521
Transplantacija bubrega u bolesnika s lupusnim nefritisom
Transplantacija bubrega u bolesnika s lupusnim nefritisom // Liječnički vjesnik, 136 (2014), 219-223 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 742521 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Transplantacija bubrega u bolesnika s lupusnim nefritisom
(Renal transplantation in patients with lupus nephritis)
Autori
Katalinić, L ; Eliasson, E ; Bubić-Filipi, Lj ; Anić, Branimir ; Bašić-Jukić, Nikolina
Izvornik
Liječnički vjesnik (0024-3477) 136
(2014);
219-223
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
Sistemski eritemski lupus; Lupusni nefritis; Transplantacija bubrega
(Systemic lupus erythematosus; Lupus nephritis; Renal transplantation)
Sažetak
Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), associated with high morbidity and mortality. Up to 60% of SLE patients develop LN, and despite novel and potent therapeutic regimens, 5 to 22% develop end-stage renal disease within 15 years of diagnosis. While LN primarily affects younger individuals, it is important to choose optimal method of renal replacement therapy for those who develop end-stage renal disease. Numerous studies were carried out trying to solve problems of treatment of patients with LN. Increased risk of infections, disease recurrence in renal allograft, undefined criteria for follow-up of disease activity after transplantation, as well as higher inci- dence of rejection episodes and thrombotic events are well known risks which have postponed and restricted access to transplantation for patients with LN for long-time. However, numerous studies have demonstrated similar long-term survival in patients treated with haemodialysis or peritoneal dialysis, with clear superiority of renal transplantation regarding the prolonged survival and better quality of life for SLE patients. Many questions are still waiting for answers. Close cooperation between nephrologists and immunologists provides the best treatment for SLE patients with end-stage renal disease.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE